SEC Form 4 · accession 0001162194-17-000055
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas Khadder
Officer — See Remarks
Period of report
May 22, 2017
Accepted (ET)
May 23, 2017 · 6:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2017 | M | 2,633 | $0.00 | A | 2,633 | D | |
| Common Stock | May 22, 2017 | F | 1,102 | $5.46 | D | 1,531 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 22, 2017 | M | 2,633 | D | — | — | Common Stock | 2,633 | 28,967 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F2On February 13, 2017, the Reporting Person was granted 31,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
Remarks
SENIOR VP, LEGAL AFFAIRS, GENERAL COUNSEL, CHIEF COMPLIANCE OFFICER AND SECRETARY